S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.

Biochem Biophys Res Commun 2014 Mar 12;446(1):404-9. Epub 2014 Mar 12.

Biomed Division of LEITAT Technological Center, Barcelona Science Park, 08028 Barcelona, Spain. Electronic address:

Secreted by tumor and stromal cells, S100 proteins exert their biological functions via the interaction with surface receptors. The most described receptor is the receptor for advanced glycation end-products (RAGE), thereby participating in the S100-dependent cell migration, invasion, tumor growth, angiogenesis and metastasis. Several approaches have been described for determining this interaction. Here we describe an easy, specific and highly reproducible ELISA-based method, by optimizing several parameters such as the binding and blocking buffer, interaction time and concentrations, directed to screen chemical and biological inhibitors of this interaction for S100A4, S100A7 and S100P proteins. The efficiency of the protocol was validated by using well described neutralizing agents of the RAGE receptor and of the S100A4 activity. The methodology described here will allow future works with other members of the S100 protein family and their receptors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2014.02.143DOI Listing
March 2014
1 Read

Publication Analysis

Top Keywords

advanced glycation
8
receptor advanced
8
glycation end-products
8
easy specific
4
specific highly
4
s100a4 activity
4
describe easy
4
interaction describe
4
highly reproducible
4
receptor s100a4
4
rage receptor
4
agents rage
4
reproducible elisa-based
4
activity methodology
4
elisa-based method
4
described determining
4
growth angiogenesis
4
tumor growth
4
proteins efficiency
4
invasion tumor
4

Similar Publications